Sexually transmitted infection caused by the gram-negative bacteria Neisseria gonorrhoeae
Second most common bacterial STI in UK (after chlamydia)
Predominantly affects people under the age of 25 and men who has sex with men
Pathophysiology:
Transmitted through unprotected vaginal/oral/anal sex
Can be vertically transmitted from mother to child
Gram-negativediplococcus that has a strong affinity for mucous membranes
Can infect the uterus, urethra, cervix, fallopian tubes, ovaries, testicles, rectum, throat and the eyes
Once adhered to the mucous membrane, it invades the host cell and causes acute inflammation
Has surface proteins that bind to the receptors of immune cells - prevents immune response
Risk factors:
Aged <25 years
Men who have sex with men
Living in high density urban areas
Previous gonorrhoea infection
Multiple sexual partners
Gonorrhoea is often asymptomatic (50% of females), but symptoms can occur 2-5 days following infection
Female symptoms:
Altered/ increased vaginal discharge - thin, watery, green or yellow
Dysuria
Dyspareunia
Lower abdominal pain
Rarely intermenstrual and/or post-coital bleeding
Female signs on exam:
Mucopurulent endocervical discharge
Easily induced cervical bleeding
Pelvic tenderness
Often examination can be normal
Male symptoms:
Mucopurulent urethral discharge
Dysuria
Male signs on exam:
Mucopurulent urethral discharge
Epididymal tenderness
Rectal infection symptoms:
Usually asymptomatic
Anal discharge
Anal pain/discomfort
Prostatitis symptoms:
Perineal pain
Dysuria
Prostate tenderness on exam
Diagnosis is with a nucleic acid amplification testing (NAAT) and a charcoal endocervical swab
NAAT:
Detects the RNA and DNA of gonorrhoea
Rectal and pharyngeal swabs are recommended in all men who have sex with men and in those with risk factors
Females - Endocervical/vaginal swab
Males - first pass urine
Charcoal swab:
Sent for microscopy, culture and sensitivities (NAAT can't give this)
Amies transport medium
Females - endocervical/urethral swab
Males - urethral/meatal swab
Management (uncomplicated)
Referral to GUM clinics for testing, treatment and contact tracing
Management depends on if antibiotic sensitivities are known
Sensitivities not known - single dose IM ceftriaxone 1g
Sensitivities known - single dose oral ciprofloxacin 500mg
All patients should have a follow-up “test of cure” given the high antibiotic resistance. This is with NAAT testing if they are asymptomatic, or cultures where they are symptomatic. BASHH recommend a test of cure at least:
72 hours after treatment for culture
7 days after treatment for RNA NAAT
14 days after treatment for DNA NAAT
Other factors to consider are:
Abstain from sex for seven days of treatment of all partners to reduce the risk of re-infection
Test for and treat any other sexually transmitted infections
Provide advice about ways to prevent future infection
Consider safeguarding issues and sexual abuse in children and young people
Complications
Pelvic inflammatory disease
Chronic pelvic pain
Infertility
Epididymo-orchitis (men)
Prostatitis (men)
Conjunctivitis
Urethral strictures
Disseminated gonococcal infection
Skin lesions
Fitz-Hugh-Curtis syndrome (inflammation of the liver capsule with adhesion formation)
Septic arthritis
Endocarditis
Gonococcal conjunctivitis in neonates:
Vertical transmission from mother
Neonatal conjunctivitis is called ophthalmia neonatorum
Medical emergency - associated with sepsis, perforation of the eye and blindness
Disseminated gonococcal infection:
Complication of untreated infection, where bacteria spreads to the skin and joints:
Various non-specific skin lesions
Polyarthralgia
Migratory polyarthritis
Tenosynovitis (inflammation of synovial membrane of tendons)